ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,909.19
      -0.01%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. AbbVie Inc (ABBV)

      7. AbbVie Inc (ABBV) Financials

      AbbVie Inc

      AbbVie Inc (ABBV)

      Abbvie CDR
      185.16
      2.99
      (1.64%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      185.00
      -0.16
      (-0.09%)
      After Hours: 7:58PM
      Delayed by 15 minutes

      AbbVie Inc Financial Summary

      The current ABBV market cap is 326.69B. The company's latest EPS is USD 2.7539 and P/E is 67.24.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 12.24B14.03B13.93B14.3B12.31B
      Operating Income 2.77B4.51B2.28B3.2B2.8B
      Net Income 239M2.02B1.78B822M1.37B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 34.16B45.8B56.2B58.05B54.5B
      Operating Income 12.98B11.36B17.92B18.12B12.76B
      Net Income 7.88B4.62B11.54B11.84B4.86B

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 134.54B135.37B136.22B134.71B148.87B
      Total Liabilities 121.24B122.47B124.09B124.31B140.83B
      Total Equity 13.3B12.9B12.13B10.4B8.05B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 89.12B150.57B146.53B138.81B134.71B
      Total Liabilities 97.29B137.47B131.09B121.52B124.31B
      Total Equity -8.17B13.1B15.44B17.29B10.4B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 4.19B10.51B18.09B22.84B4.04B
      Investing -499M-840M-1.21B-2.01B-9.59B
      Financing -6.19B-10.11B-12.77B-17.22B10.82B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 13.32B17.59B22.78B24.94B22.84B
      Investing 596M-37.56B-2.34B-623M-2.01B
      Financing 18.71B-11.5B-19.04B-24.8B-17.22B

      Stats and Ratios

      Market Cap 326.69B
      Price to Earnings Ratio 67.24
      Price to Sales Ratio 6
      Price to Cash Ratio 25.52
      Price to Book Ratio 31.45
      Dividend Yield 3.31%

      Share Statistics

      Shares Outstanding 1.77B
      Average Volume (1 week) 4.97M
      Average Volume (1 Month) 5.7M
      52 Week Change 30.81%
      52 Week High 186.85
      52 Week Low 135.85
      Spread (Intraday) 1.7 (0.91%)

      Company Info

      Company Name AbbVie Inc
      Address 1521 concord pike suite 201
      wilmington, delaware 19803
      Website https://www.abbvie.com
      Industry pharmaceutical preparations (2834)